Mountain Cedar Pollen

NDC 49643-371 · Allermed Laboratories, Inc.

Generic nameJuniperus sabinoides

Dosage formINJECTION

RouteCUTANEOUS, INTRADERMAL, SUBCUTANEOUS

Active ingredient(s)JUNIPERUS ASHEI POLLEN

Strength.05 g/mL

Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]

Marketing categoryBLA

Packages

49643-371-05 — 5 mL in 1 VIAL, MULTI-DOSE (49643-371-05)

49643-371-10 — 10 mL in 1 VIAL, MULTI-DOSE (49643-371-10)

49643-371-30 — 30 mL in 1 VIAL, MULTI-DOSE (49643-371-30)

49643-371-50 — 50 mL in 1 VIAL, MULTI-DOSE (49643-371-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0268-1097 — Cedar Mountain, 0268-1098 — Cedar Mountain, 0268-6614 — Mountain Cedar, 22840-1466 — Juniperus ashei, 22840-4438 — Juniperus ashei, 22840-5417 — Juniperus ashei, 65044-1336 — Cedar, Mountain Juniperus ashei, 65044-1337 — Cedar, Mountain Juniperus ashei, 65044-1339 — Cedar, Mountain Juniperus ashei

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels